We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFI icon
3001
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.6M
$30K ﹤0.01%
752
+614
+445% +$25.6K
PRQR icon
3002
ProQR Therapeutics
PRQR
$258M
$30K ﹤0.01%
14,132
+8,796
+165% +$26.9K
RGNX icon
3003
Regenxbio
RGNX
$689M
$30K ﹤0.01%
1,582
-4,810
-75% -$106K
SOHU
3004
Sohu.com
SOHU
$368M
$30K ﹤0.01%
+2,025
New +$30.5K
SXC icon
3005
SunCoke Energy
SXC
$795M
$30K ﹤0.01%
3,354
+2,857
+575% +$26.1K
YMAB
3006
DELISTED
Y-mAbs Therapeutics
YMAB
$30K ﹤0.01%
5,899
+5,323
+924% +$21.7K
CONN
3007
DELISTED
Conn's Inc.
CONN
$30K ﹤0.01%
4,938
-11,784
-70% -$100K
SBOW
3008
DELISTED
SilverBow Resources, Inc.
SBOW
$30K ﹤0.01%
1,304
+830
+175% +$20.5K
LICY
3009
DELISTED
Li-Cycle Holdings Corp.
LICY
$30K ﹤0.01%
662
+381
+136% +$16.8K
AVID
3010
DELISTED
Avid Technology Inc
AVID
$30K ﹤0.01%
937
+537
+134% +$15.9K
AIV
3011
Aimco
AIV
$382M
$29K ﹤0.01%
3,807
-150
-4% -$1.12K
ARES icon
3012
Ares Management
ARES
$32.9B
$29K ﹤0.01%
348
-2,658
-88% -$211K
ARKF icon
3013
ARK Blockchain & Fintech Innovation ETF
ARKF
$773M
$29K ﹤0.01%
1,524
-679
-31% -$12K
ARKR icon
3014
Ark Restaurants
ARKR
$20.2M
$29K ﹤0.01%
1,651
+1,559
+1,695% +$28.6K
ARQT icon
3015
Arcutis Biotherapeutics
ARQT
$3.22B
$29K ﹤0.01%
2,624
-6,241
-70% -$90.3K
AVDX
3016
DELISTED
AvidXchange
AVDX
$29K ﹤0.01%
3,708
-5,741
-61% -$55.2K
AZEK
3017
DELISTED
The AZEK Co
AZEK
$29K ﹤0.01%
1,206
+1,060
+726% +$25.1K
BCLI
3018
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$29K ﹤0.01%
591
+521
+744% +$15.1K
BGS icon
3019
B&G Foods
BGS
$294M
$29K ﹤0.01%
1,871
+1,039
+125% +$14.5K
BTAI icon
3020
BioXcel Therapeutics
BTAI
$35.8M
$29K ﹤0.01%
96
+65
+210% +$27.8K
BUSE icon
3021
First Busey Corp
BUSE
$2.58B
$29K ﹤0.01%
1,409
+992
+238% +$23.2K
CCJ icon
3022
Cameco
CCJ
$42.8B
$29K ﹤0.01%
1,113
-2,871
-72% -$75.9K
CLMT icon
3023
Calumet Specialty Products
CLMT
$4.24B
$29K ﹤0.01%
1,689
+1,301
+335% +$23.1K
CLPR
3024
Clipper Realty
CLPR
$53.6M
$29K ﹤0.01%
5,150
+3,600
+232% +$23.9K
CMTG icon
3025
Claros Mortgage Trust
CMTG
$272M
$29K ﹤0.01%
2,521
+1,693
+204% +$24.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.